Everyday Health on MSN
Blockbuster Cancer Drug Keytruda Now Available as a Time-Saving Shot
So-called checkpoint proteins on immune cells serve as gatekeepers that are supposed to keep foreign invaders from entering healthy cells. Certain cancers use these checkpoints to avoid detection.
The U.S. Food and Drug Administration (FDA) on Friday approved Merck & Co Inc.’s (NYSE:MRK) Keytruda (pembrolizumab) for adult patients with resectable locally advanced head and neck squamous cell ...
University of Queensland researcher Arutha Kulasinghe studied lung biopsies from the tumours of almost 250 patients with ...
Medications that prevent HIV, shrink tumors and treat seizures were invented with government funding. At research ...
Merck & Co.’s Keytruda has become the first immunotherapy approved by the FDA to be used around surgery to treat resectable locally advanced head and neck cancer. But the breakthrough approval comes ...
Merck & Co Inc (NYSE:MRK) on Thursday said the Phase 3 KEYNOTE-B96 trial (also known as ENGOT-ov65), met its primary endpoint of progression-free survival (PFS) for platinum-resistant recurrent ...
Merck will reduce its staff by approximately 6,000 in “some areas of our global workforce,” the New Jersey drugmaker told Fierce Pharma. The cuts will affect 8% of the company's headcount. Word of the ...
Merck (NYSE:MRK) got U.S. Patent and Trademark Office support in its ongoing patent dispute with Halozyme Therapeutics (NASDAQ:HALO) related to an injectable version of the New Jersey-based pharma ...
The FDA approved Merck's Keytruda Qlex, a new under-the-skin version of the cancer drug that can be injected in just 1-2 minutes, offering faster and more convenient treatment than traditional IV ...
As they lose the right to work, Ukrainians who were once welcomed to US fear they will have to leave
Natalia’s son does not remember Ukraine. He thinks he’s been living in the United States his entire life. “He doesn’t understand why he has to leave,” her friend Tatiana explained. But unless there is ...
Nancy Chen is a CBS News correspondent, reporting across all broadcasts and platforms. Prior to joining CBS News, Chen was a weekday anchor and reporter at WJLA-TV in Washington, D.C. She joined ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback